The COVID-19 pandemic should serve as a wake up call.
Pharmaceutical companies are interested in appearing concerned about drug affordability, but their efforts are always superficial and short-lived.
It’s hard to even look at my medical bills.
At what point are drug companies choosing to harm people in favor of making a profit?
I had to start stockpiling my insulin.
No one should ever have to wonder if they can afford to stay alive.
Real people like me are struggling.
I want pharmaceutical companies to remember the people who are using and paying for their medications.
As patients, we have the power.
It is time for pharmaceutical companies to make drugs affordable rather than spending frivolously or hoarding money for the executives.
I live at the mercy of drug prices.
I find this terrifying, personally, and unjust for all people who have survived organ transplantation only to live with the constant risk of being unable to afford expensive drugs they need to keep them alive.
These drugs could save her life.
But this isn’t a board game. Vertex has a real-life monopoly on expensive CF drugs, and the next iteration could keep my daughter out of the hospital so she can continue her studies and pursue her dressage dreams.
Wall Street and Big Pharma Team Up To Push High Prices For COVID-19 Treatments and Vaccines
As COVID-19 ground the U.S. economy to a halt, one sector has remained invigorated by the promise of huge profits: Wall Street.
